In both murine models and cancer patients, tumors are enriched in arginase I-producing MDSC, and arginine metabolism in the tumor microenvironment leads to downregulation of CD3ζ chain and suppression of proliferative capacity in both CD4+ and CD8+ T cells (58, 59). Here, CD4 is linked to neoplasm.